Dennis Hom - Jul 13, 2023 Form 3 Insider Report for Sagimet Biosciences Inc. (SGMT)

Role
Chief Financial Officer
Signature
/s/ Dennis Hom
Stock symbol
SGMT
Transactions as of
Jul 13, 2023
Transactions value $
$0
Form type
3
Date filed
7/13/2023, 09:00 PM
Next filing
Jul 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SGMT Stock Option (Right to Buy) Jul 13, 2023 Common Stock 111K $6.36 Direct F1
holding SGMT Stock Option (Right to Buy) Jul 13, 2023 Common Stock 9.29K $6.36 Direct F1
holding SGMT Stock Option (Right to Buy) Jul 13, 2023 Common Stock 137K $6.36 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option are fully vested and exercisable as of the date hereof.
F2 The shares underlying this option shall vest in forty-eight (48) equal monthly installments following January 27, 2021, subject to the Reporting Person's continued service on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney